News
Join CILcare at our booth at BioFIT 2022!
CILcare is glad to announce that Marie Peytavy-Izard, Marketing & Business Development Director, and Susanna Malmström, Alliances Director, will be holding a booth at the 2022 edition of BioFIT. Taking place in Strasbourg, France on November 29th and 30th, BioFIT...
CILcare-CBSET receive a Hearing Technology Innovator Award
LEXINGTON, Mass., USA, October 21st, 2022 — CILcare, a leading R&D services company dedicated to ear disorders, announced today that the company and its partner CBSET Inc., a not-for-profit translational research institute, have been recognized for their...
CILcare-CBSET nominated at the Hearing Technology Innovator Awards 2022
CILcare and its partner CBSET are proud to announce their nomination at the Hearing Technology Innovator Awards, which highlights their innovative auditory services that accelerate research and development of novel therapeutics. Lexington, MA - September 07th, 2022 -...
CILcare to present its advances on preclinical hearing loss models at IEB 2022
CILcare is glad to announce that its R&D team will be presenting its latest advances on preclinical hearing loss models at the 57th Inner Ear Biology workshop in Trieste, Italy, on September 10-13 2022. CILcare’s R&D team is looking forward to joining the next...
CILcare to give presentations on ototoxicity at ICT 2022
CILcare is pleased to announce that Marie-Pierre Pasdelou, Co-Founder & Chief Regulatory Officer, and Lise Byelyayeva, Business Developer, will be in Maastricht on September 18-21, 2022 to give presentations about CILcare's expertise on ototoxicity at the 16th...
Watch CILcare’s presentation on Chronic Inflammatory Diseases and Hearing Loss!
Have you missed CILcare's presentation on chronic inflammatory diseases and hearing loss at Inner Ear Disorders Therapeutics Summit 2022? Mathieu SCHUE, PhD, CILcare’s Project Director in Drug Development and Translational Research, held an official presentation on...
CILcare to give a presentation on a awake hyperacusis screening model at FENS Forum
We are pleased to announce that Camille Dejean, Research Engineer at CILcare and PhD student in collaboration with the Institut Pour l'Audition and Pasteur Institute, will be at the Federation of European Neuroscience Societies' 2022 Forum on July 12th to give a...
CILcare to present results on ototoxic side effects of cancer and covid-19 treatments at NF Conference
We are pleased to announce that CILcare's Chief Scientific Officer, Sylvie Pucheu, PhD, will be at the Children Tumour Foundation's NF Conference in Philadelphia on June 19th to give a poster presentation on the ototoxic side effects of cancer and Covid-19 treatments....
